Hello, everyone. Sincere apologies for the delayed start, but we were experiencing those ubiquitous technical difficulties that can stop you dead in your tracks. Nonetheless, we are soldiering on. And so here are a few tidbits that you may have missed. Meanwhile, we are reaching for yet another cup of stimulation to compensate for the disturbances. Hope your day goes well...
Merck Buys Vaccine Unit From Hawaii Biotech (Honolulu Star-Advertiser)
Lilly Closes $180M Deal For Alnara Pharmaceuticals (Associated Press)
FDA Accepts MannKind Resubmission For Affrezza (PharmaTimes)